Stock markets will be driven by quarterly earnings by index majors, global trends and the RBI's interest rate decision this week after digesting news on budget proposals and US Federal policy......
Drugmaker Lupin Ltd said on Monday its US-based arm Lupin Pharmaceuticals has received a tentative approval from the US health regulator for Eszopiclone tablets used in the treatment of sleep......
This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally. Kyowa Pharmaceutical Industry, drug major Lupin's Japanese subsidiary, has......
Drug maker Lupin Ltd said it acquired the pharmaceutical business of Rubamin group, for an undisclosed amount. The company acquired Rubamin Laboratories Ltd, the subsidiary of the Rubamin group......
Lupin Ltd on Thursday said it has received USFDA approval for its Abbreviated New Drug Application for multiple strengths of antibiotic Cephalexin capsules.The approval is for Cephalexin capsules......